8 April 2023
RNZ's Kim Hill speaks to a participant in our CAR T-cell clinical trial, poet Michele Leggott.
Michele Leggott's latest book of poetry, Face to the Sky, explores her encounter with 19th-century New Zealand botanical artist Emily Cumming Harris.
But there's more to this story - Michele was battling non-Hodgkin's lymphoma while working on the book.
In early 2020, Michele received her diagnosis, just as the Covid-19 lockdowns began. Chemotherapy, radiotherapy, and a stem cell transplant in 2021 failed to cure her cancer. Finally, in early 2022, Michele was able to participate in a CAR T-cell therapy trial at the Malaghan Institute in Wellington.
"This is the future ... The Malaghan trial, the goal of that is to get publicly funded CAR T in this country so that you don't have to be on a trial to get it. If that can happen, it'll bring down hospital costs, you'll save lives."
Related articles
Marsden funding to drive discovery and innovation in cancer, allergy and infectious disease research
5 November 2025
Eradicating H. Pylori bacterial infection to reduce stomach cancer
30 October 2025
Developing next generation CAR T-cell therapies for more equitable cancer care
30 October 2025
Making local impact using global training in liver cancer research
30 October 2025
Faster CARs: overcoming cellular exhaustion to enhance cancer immunotherapies
29 October 2025
Improving immunotherapies for lung cancer
29 October 2025